T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
The ONE Group
STKS
$56.8M
| $130K | ﹤0.01% |
23,554
| – | – |
|
|
VTNR
2602
DELISTED
Vertex Energy, Inc
VTNR
| $130K | ﹤0.01% |
29,046
+6,597
| +29% | +$33.9K |
|
|
IAS
2603
DELISTED
Integral Ad Science
IAS
| $129K | ﹤0.01% |
+10,787
| New | +$167K |
|
2604
Inogen
INGN
$154M
| $129K | ﹤0.01% |
24,548
+8,643
| +54% | +$61.4K |
|
|
ROVR
2605
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $129K | ﹤0.01% |
20,596
-136,243
| -87% | -$813K |
|
2606
American Superconductor
AMSC
$1.56B
| $128K | ﹤0.01% |
16,911
-19,489
| -54% | -$162K |
|
2607
Ocular Therapeutix
OCUL
$2.23B
| $128K | ﹤0.01% |
40,485
+1,846
| +5% | +$7.55K |
|
|
BIG
2608
DELISTED
Big Lots, Inc.
BIG
| $128K | ﹤0.01% |
24,918
+381
| +2% | +$2.9K |
|
2609
Atea Pharmaceuticals
AVIR
$424M
| $127K | ﹤0.01% |
42,242
+1,010
| +2% | +$3.44K |
|
2610
Pixelworks
PXLW
$43.9M
| $126K | ﹤0.01% |
9,292
| – | – |
|
2611
Ring Energy
REI
$349M
| $126K | ﹤0.01% |
64,179
| – | – |
|
2612
Hippo Holdings
HIPO
$876M
| $125K | ﹤0.01% |
15,627
+177
| +1% | +$2.23K |
|
2613
Evolv Technologies
EVLV
$1.03B
| $124K | ﹤0.01% |
25,353
+2,520
| +11% | +$15.5K |
|
|
XRN
2614
Chiron Real Estate Inc
XRN
$487M
| $124K | ﹤0.01% |
2,757
+301
| +12% | +$14.4K |
|
|
OPI
2615
DELISTED
Office Properties Income Trust
OPI
| $123K | ﹤0.01% |
29,929
-15,649
| -34% | -$109K |
|
2616
Arcutis Biotherapeutics
ARQT
$3.26B
| $122K | ﹤0.01% |
22,947
+622
| +3% | +$5.29K |
|
|
EBIX
2617
DELISTED
Ebix Inc
EBIX
| $121K | ﹤0.01% |
12,211
-35,877
| -75% | -$698K |
|
2618
Innodata
INOD
$1.97B
| $120K | ﹤0.01% |
13,959
-1,561
| -10% | -$17.5K |
|
|
GLDD
2619
DELISTED
Great Lakes Dredge & Dock
GLDD
| $118K | ﹤0.01% |
14,802
+1,286
| +10% | +$10.7K |
|
2620
Stoke Therapeutics
STOK
$2.1B
| $118K | ﹤0.01% |
29,789
-329,133
| -92% | -$2.16M |
|
2621
Karyopharm Therapeutics
KPTI
$44.4M
| $117K | ﹤0.01% |
5,808
+1,267
| +28% | +$28.4K |
|
2622
AST SpaceMobile
ASTS
$21.5B
| $116K | ﹤0.01% |
30,454
+5,165
| +20% | +$20.8K |
|
2623
SGHC Ltd
SGHC
$6.6B
| $116K | ﹤0.01% |
31,285
+3,625
| +13% | +$12K |
|
2624
Tango Therapeutics
TNGX
$4.36B
| $116K | ﹤0.01% |
+10,216
| New | +$62.3K |
|
2625
Energy Vault
NRGV
$683M
| $114K | ﹤0.01% |
44,584
+2,959
| +7% | +$8.85K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.